Breaking News
Close
0

Pre-Open Stock Movers 05/10: Biohaven Surges on Takeover; Upstart, GoodRx Slashed on Outlook (more...)

May 10, 2022 09:18
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

Pre-Open Stock Movers:

Biohaven Pharmaceutical (BHVN) 71% HIGHER; Pfizer Inc. (NYSE:PFE) and Biohaven Pharmaceutical Holding Company Ltd. (BHVN) today announced that the companies have entered into a definitive agreement under which Pfizer will acquire Biohaven, the maker of NURTEC® ODT, an innovative dual-acting migraine therapy approved for both acute treatment and episodic prevention of migraine in adults.

Upstart Holdings (NASDAQ:UPST) 57% LOWER; reported Q1 EPS of $0.61, $0.07 better than the analyst estimate of $0.54. Revenue for the quarter came in at $310 million versus the consensus estimate of $300.25 million. Upstart Holdings sees Q2 2022 revenue of $295-305 million, versus the consensus of $335 million.

Vroom (VRM) 53% HIGHER; reported Q1 EPS of ($0.71), $0.30 better than the analyst estimate of ($1.01). Revenue for the quarter came in at $923.78 million versus the consensus estimate of $874.09 million.

GoodRx Holdings, Inc. (GDRX) 31% LOWER; reported Q1 EPS of $0.10, $0.02 better than the analyst estimate of $0.08. Revenue for the quarter came in at $203.3 million versus the consensus estimate of $200.2 million. GoodRx Holdings, Inc. sees Q2 2022 revenue of $190 million, versus the consensus of $215.6 million.

Novavax (NASDAQ:NVAX) 25% LOWER; reported Q1 EPS of $2.56, $0.13 worse than the analyst estimate of $2.69. Revenue for the quarter came in at $704 million versus the consensus estimate of $845.2 million. Novavax sees FY2022 revenue of $4-5 billion.

Duke Realty Corporation (NYSE:DRE) 19% HIGHER; Prologis , Inc. (NYSE:PLD), the global leader in logistics real estate, today sent a letter to James B. Connor, Chairman and Chief Executive Officer of Duke Realty Corporation (DRE) proposing to acquire Duke Realty in an all-stock transaction.

Peloton (NASDAQ:PTON) 17% LOWER; reported Q3 EPS of ($2.27), $1.42 worse than the analyst estimate of ($0.85). Revenue for the quarter came in at $964.3 million versus the consensus estimate of $972.88 million. Peloton sees Q4 2022 revenue of $675-700 million, versus the consensus of $821.7 million.

Shockwave Medical (NASDAQ:SWAV) 16% HIGHER; reported Q1 EPS of $0.41, $0.23 better than the analyst estimate of $0.18. Revenue for the quarter came in at $93.6 million versus the consensus estimate of $86.41 million. Shockwave Medical sees Q2 2022 revenue of $435-455 million, versus the consensus of $417.9 million.

Clover (JO:CLRJ) Health Investments (CLOV) 14% HIGHER; reported revenue for the first quarter of $874.4 million versus the consensus estimate of $787.4 million. Clover Health Investments sees FY2022 revenue of $3-3.4 billion, versus the consensus of $3.24 billion.

Groupon (NASDAQ:GRPN) 12% LOWER; reported Q1 EPS of ($0.80), $0.28 worse than the analyst estimate of ($0.52). Revenue for the quarter came in at $153.3 million versus the consensus estimate of $165.81 million. Groupon sees Q2 2022 revenue of $155-165 million, versus the consensus of $202.4 million. Groupon sees FY2022 revenue of $670-700 million, versus the consensus of $837.08 million.

Hims & Hers Health, Inc. (HIMS) 7% HIGHER; reported Q1 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $101.3 million versus the consensus estimate of $91.17 million. Hims & Hers Health, Inc. sees FY2022 revenue of $103-106 million, versus the consensus of $92.45 million. Hims & Hers Health, Inc. sees FY2022 revenue of $410-425 million, versus the consensus of $377.85 million.

RingCentral, Inc. (NYSE:RNG) 7% LOWER; reported Q1 EPS of $0.39, $0.05 better than the analyst estimate of $0.34. Revenue for the quarter came in at $468 million versus the consensus estimate of $458.67 million. RingCentral, Inc. sees Q2 2022 EPS of $0.40-$0.41, versus the consensus of $0.38. RingCentral, Inc. sees Q2 2022 revenue of $475.5-479.5 million, versus the consensus of $477.2 million. RingCentral, Inc. sees FY2022 EPS of $1.83-$1.87, versus the consensus of $1.71. RingCentral, Inc. sees FY2022 revenue of $1.99-2.015 billion, versus the consensus of $2.01 billion.

XPO Logistics (NYSE:XPO) 6% HIGHER; reported Q1 EPS of $1.25, $0.32 better than the analyst estimate of $0.93. Revenue for the quarter came in at $3.47 billion versus the consensus estimate of $3.22 billion. XPO Logistics sees FY2022 EPS of $5.20-$5.60, versus the consensus of $5.19.

Rover Group (ROVR) 5% HIGHER; reported Q1 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $28 million versus the consensus estimate of $26.54 million. Rover Group sees Q2 2022 revenue of $41-43 million, versus the consensus of $41.2 million. Rover Group sees FY2022 revenue of $160-180 million, versus the consensus of $174.07 million.

Autoliv (NYSE:ALV), Inc. (ALV) 5% HIGHER; UBS upgraded from Neutral to Buy with a price target of $90.00 (from $103.00).

AMC Entertainment (NYSE:AMC) 5% HIGHER; reported Q1 EPS of ($0.52), $0.11 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $785.7 million versus the consensus estimate of $736.23 million.

Microchip Technology (NASDAQ:MCHP) 4% HIGHER; reported Q4 EPS of $1.35, $0.10 better than the analyst estimate of $1.25. Revenue for the quarter came in at $1.84 billion versus the consensus estimate of $1.82 billion. Microchip Technology sees Q1 2023 EPS of $1.32-$1.36, versus the consensus of $1.28. Microchip Technology sees Q1 2023 revenue of $1.918-1.992 billion, versus the consensus of $1.86 billion.

Uber (NYSE:UBER) 4% HIGHER; CEO bought 200,000 shares

Blink Charging (BLNK) 3% HIGHER; reported Q1 EPS of ($0.36), $0.05 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $9.8 million versus the consensus estimate of $6.87 million.

Tiga Acquisition Corp. (TINV) 2% HIGHER; LGBTQ+ dating app Grindr will come public in a merger with the SPAC.

Pre-Open Stock Movers 05/10: Biohaven Surges on Takeover; Upstart, GoodRx Slashed on Outlook (more...)
 

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Our Apps
DOWNLOAD APPApp store
Investing.com
© 2007-2022 Fusion Media Limited. All Rights Reserved.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
  • Sign up for FREE and get:
  • Real-Time Alerts
  • Advanced Portfolio Features
  • Personalised Charts
  • Fully-Synced App
Continue with Google
or
Sign up with Email